Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.2877
Delayed Data
As of Jan 20
 -0.0023 / -0.79%
Today’s Change
0.28
Today|||52-Week Range
1.12
-6.71%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.29
Today’s open0.29
Day’s range0.28 - 0.30
Volume1,399,004
Average volume (3 months)1,631,444
Market cap$74.0M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...-0.05-0.80%
IPCIIntellipharmaceutics...-0.06-2.31%
CASICASI Pharmaceuticals...-0.01-0.82%
ALIMAlimera Sciences Inc+0.01+0.85%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 10, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts


Search for Jobs